Kennedy Capital Management LLC Trims Holdings in GE HealthCare Technologies Inc. $GEHC

Kennedy Capital Management LLC trimmed its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 35.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 59,392 shares of the company’s stock after selling 32,328 shares during the period. Kennedy Capital Management LLC’s holdings in GE HealthCare Technologies were worth $4,871,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Western Wealth Management LLC lifted its holdings in GE HealthCare Technologies by 2.4% in the 4th quarter. Western Wealth Management LLC now owns 5,240 shares of the company’s stock valued at $430,000 after purchasing an additional 125 shares in the last quarter. United Community Bank lifted its holdings in shares of GE HealthCare Technologies by 10.2% during the 4th quarter. United Community Bank now owns 1,410 shares of the company’s stock worth $116,000 after acquiring an additional 130 shares during the period. Parkside Financial Bank & Trust lifted its holdings in shares of GE HealthCare Technologies by 3.9% during the 4th quarter. Parkside Financial Bank & Trust now owns 3,567 shares of the company’s stock worth $293,000 after acquiring an additional 134 shares during the period. Thoma Capital Management LLC lifted its holdings in shares of GE HealthCare Technologies by 1.4% during the 4th quarter. Thoma Capital Management LLC now owns 9,918 shares of the company’s stock worth $814,000 after acquiring an additional 136 shares during the period. Finally, Colonial Trust Advisors lifted its holdings in shares of GE HealthCare Technologies by 11.1% during the 3rd quarter. Colonial Trust Advisors now owns 1,391 shares of the company’s stock worth $104,000 after acquiring an additional 139 shares during the period. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

GE HealthCare Technologies Stock Down 0.6%

GEHC opened at $64.76 on Tuesday. The firm has a 50 day moving average price of $66.21 and a 200 day moving average price of $75.07. The company has a market cap of $29.46 billion, a PE ratio of 15.49, a price-to-earnings-growth ratio of 1.47 and a beta of 0.74. GE HealthCare Technologies Inc. has a 1 year low of $58.75 and a 1 year high of $89.77. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.95 and a current ratio of 1.22.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). The business had revenue of $5.13 billion for the quarter, compared to analyst estimates of $5.04 billion. GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The firm’s revenue for the quarter was up 7.4% compared to the same quarter last year. During the same period last year, the company posted $1.01 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Sell-side analysts expect that GE HealthCare Technologies Inc. will post 4.89 earnings per share for the current year.

Insider Activity

In other GE HealthCare Technologies news, CFO James Saccaro bought 3,310 shares of the company’s stock in a transaction that occurred on Friday, May 1st. The stock was purchased at an average price of $60.60 per share, with a total value of $200,586.00. Following the transaction, the chief financial officer owned 87,471 shares in the company, valued at $5,300,742.60. This trade represents a 3.93% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Watkin Phoebe L. Yang bought 1,000 shares of the company’s stock in a transaction that occurred on Friday, May 8th. The shares were acquired at an average cost of $63.01 per share, with a total value of $63,010.00. Following the transaction, the director owned 13,702 shares in the company, valued at approximately $863,363.02. This represents a 7.87% increase in their position. The SEC filing for this purchase provides additional information. In the last 90 days, insiders have acquired 21,847 shares of company stock worth $1,361,355. Insiders own 0.36% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on GEHC. Piper Sandler cut their price objective on shares of GE HealthCare Technologies from $88.00 to $74.00 in a report on Thursday, April 30th. UBS Group upgraded shares of GE HealthCare Technologies from a “sell” rating to a “neutral” rating and cut their price objective for the stock from $75.00 to $69.00 in a report on Thursday, May 21st. Mizuho cut their price objective on shares of GE HealthCare Technologies from $90.00 to $80.00 in a report on Thursday, April 30th. BTIG Research cut their price objective on shares of GE HealthCare Technologies from $85.00 to $80.00 and set a “buy” rating on the stock in a report on Wednesday, April 29th. Finally, Wells Fargo & Company cut their price objective on shares of GE HealthCare Technologies from $97.00 to $75.00 and set an “overweight” rating on the stock in a report on Thursday, April 30th. Nine investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to data from MarketBeat, GE HealthCare Technologies presently has a consensus rating of “Moderate Buy” and an average target price of $80.21.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.